Analyst picks & changes

Genentech Inc.

(GNE)

The South San Francisco company's first quarter earnings were ahead of analysts' estimates.

Cowen's Lonergan raised her rating on the South San Francisco company

Read the full 279 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE